A "quickscore" method for immunohistochemical semiquantitation: Validation for oestrogen receptor in breast carcinomas

753Citations
Citations of this article
230Readers
Mendeley users who have this article in their library.

Abstract

Immunohistochemistry is increasingly used in the assessment of markers for breast cancer prognosis. Semiquantitation is frequently desirable but, other than by the use of image analysis, the approaches currently in use are cumbersome. The most common method used is the H-score which takes into consideration the staining intensity in conjunction with the percentage of cells staining positively in breast carcinoma tissue. A "quickscore" has been developed which dispenses with the need to count individual cells. The quantitative biochemical Abbott enzyme immunoassay (EIA) and the Dako immunohistochemical assay (IHA) incorporating a semiquantitative H-score, have been used as standards against which the IHA quick score for the semiquantitation of oestrogen receptor expression was tested. A good correlation was found between the quick score and the EIA, which was as good as that between the H-score and EIA. The quickscore is a valid approach and there is no advantage in using the more rigorous H-score. A positive cut off quickscore of ≥3 has been suggested.

Cite

CITATION STYLE

APA

Detre, S., Saccani Jotti, G., & Dowsett, M. (1995). A “quickscore” method for immunohistochemical semiquantitation: Validation for oestrogen receptor in breast carcinomas. Journal of Clinical Pathology, 48(9), 876–878. https://doi.org/10.1136/jcp.48.9.876

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free